[Newborn screening for cystic fibrosis in France].

doi:10.1051/medsci/2021051

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Newborn screening for cystic fibrosis in France].

Medecine sciences : M/S - 1 May 2021

Munck Anne, Cheillan David, Audrezet Marie-Pierre, Guenet David, Huet Frédéric

Abstract excerpt

Neonatal screening for cystic fibrosis has optimised the prognosis for patients allowing very early multidisciplinary care. Over the past 20 years, screening programmes have undergone major international expansion. The performances of the French neonatal cystic fibrosis screening programme, established in 2002, has met European guideline standards, with positive predictive value of 0.31 (against a minimum of...

Topics

Cystic Fibrosis
Cystic Fibrosis Transmembrane Conductance Regulator
Female
France
Humans
Infant, Newborn
Maternal Health Services
Mutation
Neonatal Screening
Pregnancy

Source

Open in PubMed

Identifiers

PMID: 34003095
DOI: 10.1051/medsci/2021051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics